MedTrace Logo

SEMS Placement Followed by Chemotherapy and Surgery for Obstructing Left-sided Colonic Cancer

NCT04039360 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 11

Last updated 2019-07-31

No results posted yet for this study

Summary

This study aimed to evaluate the safety and feasibility of SEMS followed by neoadjuvant chemotherapy prior to elective surgery for obstructing left-sided colon cancer.

Conditions

  • Complication of Treatment

Interventions

COMBINATION_PRODUCT

self-expanding metallic stent placement followed by neoadjuvant chemotherapy

Neoadjuvant chemotherapy was administered 1 week after successful SEMS placement and decompression for patient with obstructing left-sided colonic cancer. Patients received either three cycles of mFOLFOX6 repeated every 2 weeks or two cycles of CAPOX repeated every 3 weeks. Elective surgery was performed 2 weeks after completion of chemotherapy by experienced colorectal surgeons.

Sponsors & Collaborators

  • Beijing Chao Yang Hospital

    lead OTHER

Eligibility

Min Age
18 Years
Max Age
80 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2014-05-01
Primary Completion
2015-11-30
Completion
2015-11-30

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04039360 on ClinicalTrials.gov